MannKind Corp
MNKD
₹343.13
Share price
-2.46%
Change (1 day)
-29.60%
Change (1 year)
Categories
Operating Margin for MannKind Corp (MNKD)
Operating Margin as of July 2025 (TTM): 11.16%
According to MannKind Corp's latest financial reports and stock price the company's current Operating Margin is 11.16%. At the end of 2024 the company had an Operating Margin of 10.69%.
Operating Margin history for MannKind Corp from 2010 to 2025
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | 10.69% | -304.95% |
| 2023 | -5.22% | -94.05% |
| 2022 | -87.60% | -18.33% |
| 2021 | -107.27% | 21.62% |
| 2020 | -88.20% | 7.12% |
| 2019 | -82.34% | -73.55% |
| 2018 | -311.34% | -68.82% |
| 2017 | -998.57% | -1488.69% |
| 2016 | 71.91% | |
| 2012 | -485,068.57% | 50.83% |
| 2011 | -321,608.00% | 75.36% |
| 2010 | -183,397.85% | |
| 2008 | -1,515,185.00% | -48.32% |
| 2007 | -2,931,870.00% | 1171.72% |
| 2006 | -230,543.00% | |
| 2001 | -14,798.47% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Halozyme Therapeutics HALO | 55.78% | 399.82% | 🇺🇸 USA |
 Novo Nordisk NVO | 43.79% | 292.38% | 🇩🇰 Denmark |
 Merck MRK | 31.06% | 178.32% | 🇺🇸 USA |
 Eli Lilly LLY | 27.75% | 148.66% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | -147.54% | -1,422.04% | 🇺🇸 USA |
 Pfizer PFE | 12.60% | 12.90% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.